Developer docs
API playgroundTry for free, no card

Search company profiles

BrainTrip

Full company profile

uuid000apv2

Namestring
BrainTrip
Legal namestring
BrainTrip Limited
Websiteurl
braintrip.net
Company typeenum
Private
Founded yearint
2019
Descriptiontext

BrainTrip is a Slovenia-founded, Malta-incorporated medical device company that sells NeuroAI, a software-and-hardware platform for translating EEG brain-wave data into objective biomarkers of brain function. The company's two commercial products are CogniScore, an EEG-based cognitive health test that quantifies brain health on a 0–100 score and flags cognitive decline or dementia with reported 96% specificity and 88% sensitivity, and BrainAge, an EEG-based brain biological clock that estimates brain age with a stated typical error of 1.6 years and corrects for confounders such as sex and education. Both products run on a portable 24-channel EEG system that fits into a suitcase, require roughly five hours of onboarding rather than months of training, and are designed for point-of-care use by clinicians without prior EEG expertise; data is processed in the cloud under GDPR-compliant controls.

The underlying NeuroAI engine is described as a virtual neuroscientist that pairs traditional EEG signal processing with machine learning trained on more than 1,500 EEG recordings across 500 subjects, from which the company claims to have identified 400 predictive biomarkers drawn from 100 million candidate brain-wave features. CogniScore is CE-marked as an EU medical device; BrainAge is positioned for preventive-care, longevity, and clinical research use. Go-to-market is a direct enterprise sales motion using online demo booking, selling to clinics, hospitals, research labs, longevity and wellness facilities, and pharmaceutical customers, with stated intent to extend into drug discovery, personalized medicine, and large-scale neuroscience research. Revenue mechanics are not publicly disclosed but appear to combine hardware sale of the portable EEG kit with recurring cloud-analysis fees; pricing is quote-based with multi-year institutional contracts and no published tiers.

The company is privately held under BrainTrip Limited (Malta), employs 1–10 people, was founded in 2019 by co-founders Jurij and David out of a neuroscience lab, and has publicly disclosed only one funding event (Fast Track Malmo, March 2020). Its commercial track record relies heavily on credibility signals — winner of the EIB Social Innovation Tournament 2023 (one of 23 Global Innovators from 7,000+ applicants), finalist at Fundación MAPFRE Social Outreach Awards, and recipient of the European Award in Medicine 2024 — rather than named enterprise customers, disclosed revenue, or follow-on institutional capital.

Short descriptiontext

BrainTrip is a Malta-incorporated, Slovenia-based medical device company whose NeuroAI platform converts EEG recordings into cognitive-health (CogniScore) and brain-age (BrainAge) biomarkers, sold through direct enterprise demos to clinics, hospitals, research labs, longevity centers, and pharma buyers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNaxxar, Malta
HQ citystring
Naxxar
HQ countrystring
Malta
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
EEG brain diagnostics, cognitive health assessment, brain age estimation, AI brain biomarkers, neurotechnology platform
Industry2 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Neurodiagnostic Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1NeuroAI Medical Devices
TypeHardware Sales
Description

Sale of CE-marked medical devices (CogniScore and BrainAge) that include EEG hardware systems and associated software analysis. The portable systems (fitting into suitcases) are sold to healthcare institutions, clinics, and labs for point-of-care brain diagnostics.

braintrip.net
2Cloud-based EEG Analysis Software
TypeSubscription Recurring
Description

SaaS-style recurring revenue from cloud processing of EEG data. The system performs automatic data cleaning, biomarker analysis, and produces results within minutes, suggesting a subscription or per-test model for the AI analysis component.

braintrip.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Enterprise/B2B pricing through demo inquiry
ModelOtherBilling cadenceMulti-year contract
Notes

Contact-based pricing model for institutional customers including clinics, labs, and healthcare facilities. No public pricing available.

braintrip.net
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1NeuroAI
Description

Virtual neuroscientist platform that processes complex brain-wave data and produces easy-to-understand results for brain health diagnostics.

braintrip.net
+2 more records
Core offering1 text field

BrainTrip develops and sells the NeuroAI platform, an AI-driven brain wave analysis system that processes EEG recordings into diagnostic biomarkers. Built on this platform are two CE-marked medical device products: CogniScore, which quantifies cognitive health and detects cognitive decline or dementia on a 0-100 scale using 400 predictive biomarkers, and BrainAge, which estimates brain biological age from EEG recordings with 1.6-year typical error.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% accuracy with 96% specificity and 88% sensitivity for cognitive assessment
+3 more records
Product overview1 text field

BrainTrip offers a platform-plus-products architecture centered on its NeuroAI technology, a virtual neuroscientist that processes EEG brain-wave data. The company provides two distinct diagnostic products built on this platform: CogniScore, which quantifies cognitive health and detects dementia/cognitive decline with a 0-100 score, and BrainAge, which measures the brain's biological age. Both products are designed for point-of-care use, fitting into portable suitcase systems and requiring minimal training to operate.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Provides EEG-based multimodal assessment platforms for neurological and psychiatric conditions in clinical trials and clinical practice. Direct overlap with BrainTrip in using EEG + AI to quantify brain function and track cognitive change.

TypeDirect peer
Description

Digital cognitive assessment platform using AI to detect early signs of cognitive impairment and dementia. Competes for the same clinical and longevity channel customers as CogniScore, with a software-first delivery model.

TypeDirect peer
Description

Digital neurocognitive assessment platform leveraging smartphone/AR-based tasks and AI to predict conversion to Alzheimer's. Overlaps with BrainTrip in objective, AI-driven cognitive screening for early dementia detection.

TypeDirect peer
Description

AI-driven EEG analytics platform focused on clinical trials and CNS drug development, offering objective biomarkers for neurological conditions. Highly comparable to BrainTrip's pharma/drug-discovery use case.

TypeDirect peer
Description

AI-based cognitive assessment and monitoring solution that analyzes speech and behavioral patterns to detect cognitive decline. Targets similar clinical and aging-services customers as BrainTrip's CogniScore.

TypeEmerging player
Description

Maker of consumer and research-grade EEG headsets with cloud-based AI analysis of brain activity. Overlaps with BrainTrip in EEG hardware + cloud AI but is more research/consumer focused than clinical.

TypeEmerging player
Description

EEG-based brain-computer interface company building neurotechnology for everyday use, including focus and mental wellness products. Comparable technology stack (EEG + AI) targeting adjacent consumer/wellness use cases.

TypeDirect peer
Description

Develops AI-enabled EEG diagnostic devices for early detection of neurological conditions including Alzheimer's and dementia. Direct overlap with BrainTrip in portable EEG + AI for cognitive diagnostics.

TypeDirect peer
Description

Develops clinical-grade EEG systems and applies machine learning to brain data for neurological and sleep disorder assessment. Comparable in combining proprietary EEG hardware with AI-based analytics.

TypeEmerging player
Description

EEG-based sleep and cognitive monitoring headband with cloud analytics. Comparable in EEG + AI architecture and adjacent in sleep and mental wellness applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BrainTrip

Neurodiagnostic Medical Devicesbraintrip.net

BrainTrip is a Malta-incorporated, Slovenia-based medical device company whose NeuroAI platform converts EEG recordings into cognitive-health (CogniScore) and brain-age (BrainAge) biomarkers, sold through direct enterprise demos to clinics, hospitals, research labs, longevity centers, and pharma buyers.

What BrainTrip does

BrainTrip is a Slovenia-founded, Malta-incorporated medical device company that sells NeuroAI, a software-and-hardware platform for translating EEG brain-wave data into objective biomarkers of brain function. The company's two commercial products are CogniScore, an EEG-based cognitive health test that quantifies brain health on a 0–100 score and flags cognitive decline or dementia with reported 96% specificity and 88% sensitivity, and BrainAge, an EEG-based brain biological clock that estimates brain age with a stated typical error of 1.6 years and corrects for confounders such as sex and education. Both products run on a portable 24-channel EEG system that fits into a suitcase, require roughly five hours of onboarding rather than months of training, and are designed for point-of-care use by clinicians without prior EEG expertise; data is processed in the cloud under GDPR-compliant controls.

The underlying NeuroAI engine is described as a virtual neuroscientist that pairs traditional EEG signal processing with machine learning trained on more than 1,500 EEG recordings across 500 subjects, from which the company claims to have identified 400 predictive biomarkers drawn from 100 million candidate brain-wave features. CogniScore is CE-marked as an EU medical device; BrainAge is positioned for preventive-care, longevity, and clinical research use. Go-to-market is a direct enterprise sales motion using online demo booking, selling to clinics, hospitals, research labs, longevity and wellness facilities, and pharmaceutical customers, with stated intent to extend into drug discovery, personalized medicine, and large-scale neuroscience research. Revenue mechanics are not publicly disclosed but appear to combine hardware sale of the portable EEG kit with recurring cloud-analysis fees; pricing is quote-based with multi-year institutional contracts and no published tiers.

The company is privately held under BrainTrip Limited (Malta), employs 1–10 people, was founded in 2019 by co-founders Jurij and David out of a neuroscience lab, and has publicly disclosed only one funding event (Fast Track Malmo, March 2020). Its commercial track record relies heavily on credibility signals — winner of the EIB Social Innovation Tournament 2023 (one of 23 Global Innovators from 7,000+ applicants), finalist at Fundación MAPFRE Social Outreach Awards, and recipient of the European Award in Medicine 2024 — rather than named enterprise customers, disclosed revenue, or follow-on institutional capital.

BrainTrip firmographics

Firmographics
Name
BrainTrip
Legal name
BrainTrip Limited
Website
https://braintrip.net
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
BrainTrip is a Malta-incorporated, Slovenia-based medical device company whose NeuroAI platform converts EEG recordings into cognitive-health (CogniScore) and brain-age (BrainAge) biomarkers, sold through direct enterprise demos to clinics, hospitals, research labs, longevity centers, and pharma buyers.
Ownership category
akta.pro rank

BrainTrip industry classification

Industry
Product category
Neurodiagnostic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • EEG brain diagnostics
  • Cognitive health assessment
  • Brain age estimation
  • AI brain biomarkers
  • Neurotechnology platform

Where BrainTrip is headquartered

Location

Headquarters

HQ city
Naxxar
HQ country
Malta
HQ region
Europe

Offices1 record

Markets served

BrainTrip business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. NeuroAI Medical Devices: Sale of CE-marked medical devices (CogniScore and BrainAge) that include EEG hardware systems and associated software analysis. The portable systems (fitting into suitcases) are sold to healthcare institutions, clinics, and labs for point-of-care brain diagnostics.
  2. Cloud-based EEG Analysis Software: SaaS-style recurring revenue from cloud processing of EEG data. The system performs automatic data cleaning, biomarker analysis, and produces results within minutes, suggesting a subscription or per-test model for the AI analysis component.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/B2B pricing through demo inquiry

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

BrainTrip product offering

Product offering

Core offering

BrainTrip develops and sells the NeuroAI platform, an AI-driven brain wave analysis system that processes EEG recordings into diagnostic biomarkers. Built on this platform are two CE-marked medical device products: CogniScore, which quantifies cognitive health and detects cognitive decline or dementia on a 0-100 scale using 400 predictive biomarkers, and BrainAge, which estimates brain biological age from EEG recordings with 1.6-year typical error.

Product overview

BrainTrip offers a platform-plus-products architecture centered on its NeuroAI technology, a virtual neuroscientist that processes EEG brain-wave data. The company provides two distinct diagnostic products built on this platform: CogniScore, which quantifies cognitive health and detects dementia/cognitive decline with a 0-100 score, and BrainAge, which measures the brain's biological age. Both products are designed for point-of-care use, fitting into portable suitcase systems and requiring minimal training to operate.

Differentiator

Problem solved

Functional benefit

Brands

  • NeuroAI: Virtual neuroscientist platform that processes complex brain-wave data and produces easy-to-understand results for brain health diagnostics.
  • CogniScore
  • BrainAge

Quantifiable outcome

  • 95% accuracy with 96% specificity and 88% sensitivity for cognitive assessment
  • +3 more outcomes

Companies that use BrainTrip

Customer profile

Segments4 records

Ideal customer profiles4 records

BrainTrip technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

BrainTrip partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

BrainTrip competitors and assessment

Company assessment

Direct peers

  • Cumulus Neuroscience: Provides EEG-based multimodal assessment platforms for neurological and psychiatric conditions in clinical trials and clinical practice. Direct overlap with BrainTrip in using EEG + AI to quantify brain function and track cognitive change.
  • Linus Health: Digital cognitive assessment platform using AI to detect early signs of cognitive impairment and dementia. Competes for the same clinical and longevity channel customers as CogniScore, with a software-first delivery model.
  • Altoida: Digital neurocognitive assessment platform leveraging smartphone/AR-based tasks and AI to predict conversion to Alzheimer's. Overlaps with BrainTrip in objective, AI-driven cognitive screening for early dementia detection.
  • Beacon Biosignals: AI-driven EEG analytics platform focused on clinical trials and CNS drug development, offering objective biomarkers for neurological conditions. Highly comparable to BrainTrip's pharma/drug-discovery use case.
  • MyndYou: AI-based cognitive assessment and monitoring solution that analyzes speech and behavioral patterns to detect cognitive decline. Targets similar clinical and aging-services customers as BrainTrip's CogniScore.
  • iMediSync: Develops AI-enabled EEG diagnostic devices for early detection of neurological conditions including Alzheimer's and dementia. Direct overlap with BrainTrip in portable EEG + AI for cognitive diagnostics.
  • Advanced Brain Monitoring: Develops clinical-grade EEG systems and applies machine learning to brain data for neurological and sleep disorder assessment. Comparable in combining proprietary EEG hardware with AI-based analytics.

Emerging players

  • EMOTIV: Maker of consumer and research-grade EEG headsets with cloud-based AI analysis of brain activity. Overlaps with BrainTrip in EEG hardware + cloud AI but is more research/consumer focused than clinical.
  • Neurable: EEG-based brain-computer interface company building neurotechnology for everyday use, including focus and mental wellness products. Comparable technology stack (EEG + AI) targeting adjacent consumer/wellness use cases.
  • Dreem: EEG-based sleep and cognitive monitoring headband with cloud analytics. Comparable in EEG + AI architecture and adjacent in sleep and mental wellness applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

BrainTrip social profiles

Digital presence

BrainTrip compliance and trust

Trust signal

Compliance2 records

BrainTrip financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BrainTrip leadership team

Management profile

Number of profiles

Profiles2 records

BrainTrip funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BrainTrip M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BrainTrip

What does BrainTrip do?

BrainTrip develops and sells the NeuroAI platform, an AI-driven brain wave analysis system that processes EEG recordings into diagnostic biomarkers. Built on this platform are two CE-marked medical device products: CogniScore, which quantifies cognitive health and detects cognitive decline or dementia on a 0-100 scale using 400 predictive biomarkers, and BrainAge, which estimates brain biological age from EEG recordings with 1.6-year typical error.

Is BrainTrip a public or private company?

BrainTrip is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BrainTrip founded?

BrainTrip was founded in 2019. It employs 11 to 50 people.

Where is BrainTrip based?

BrainTrip is headquartered in Naxxar, Malta, in the Europe region.

How does BrainTrip make money?

Two revenue lines are on record. NeuroAI Medical Devices are the primary driver. The others are cloud-based EEG Analysis Software.

Who are BrainTrip's main competitors?

Direct peers on record are Cumulus Neuroscience, Linus Health, Altoida, Beacon Biosignals, MyndYou, iMediSync and Advanced Brain Monitoring. Emerging players are EMOTIV, Neurable and Dreem.

Does BrainTrip have an API?

No public API is recorded for BrainTrip.

What industry is BrainTrip in?

BrainTrip's product category is Neurodiagnostic Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals